FCF1P8

Across TCGA pan-cancer cohorts, FCF1P8 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated FCF1P8 data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher FCF1P8 RNA is associated with better overall survival. In most high-consensus cancer types, elevated FCF1P8 expression acts as an unfavorable survival marker, although some lineages such as HNSC and LUAD show a favorable association.

HNSC, LUAD, and BLCA are the cancer types where FCF1P8 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Quartile	IV	0.538	0.308	.001	42	view →
LUAD	OS	Median	III,IV	0.616	0.384	.027	28	view →
BLCA	DFS	Tertile	III,IV	0.660	0.415	.019	18	view →
COAD	DFS	Tertile	IV	0.279	0.591	<.001	18	view →
LIHC	DFS	Tertile	All	0.384	0.558	.008	18	view →
LAML	DFS	Median	All	0.531	0.387	.020	16	view →
THCA	OS	Tertile	IV	0.406	0.871	<.001	15	view →
UVM	DFS	Tertile	All	0.435	0.627	.043	12	view →
PAAD	DFS	Median	All	0.199	0.369	.016	12	view →
ESCA	DFS	Median	III,IV	0.569	0.323	.007	12	view →
THYM	DFS	Tertile	All	0.958	0.664	.013	9	view →
DLBC	OS	Tertile	II,III,IV	0.563	1.000	.008	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

FCF1P8–HNSC (OS)

Open the HNSC breakdown →